- Volume is elevated versus the 13-week average, confirming attention.
BHST
NASDAQ
Week ended 24 Jul 2026
Weekly Investor Report
BioHarvest Sciences Inc. Common Stock · Consumer Defensive · Packaged Foods
Latest close
1.92 USD
-28.9%
latest week
Weekly setup
Weak trend
The weekly trend is not active. Price is -52.6% below the Trend Line and sits at 0.9% of its 52-week range. The latest completed week returned -28.9%, after a -30.7% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive. The latest news-sentiment score is 52/100. Near-term considerations: earnings are due in 11d.
Setup score
24
out of 100
Latest Close
1.92 USD
24 Jul 2026
1W Return
-28.9%
latest completed week
4W Return
-30.7%
short-term follow-through
12W Return
-54.1%
quarterly tape
Trend Breadth
30.8%
16 of 52 weeks active
Volume Ratio
1.6x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Activity pressure is negative, which weakens the current setup.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
-28.9%
Latest completed week; four-week move -30.7%.
Indicator stack
17/35
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
News sentiment
52/100
44 relevant articles in the latest sentiment read.
Event risk
11d
Next report is scheduled for 10 Aug 2026; event risk rises as the date approaches.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is -52.6% below the Trend Line and sits at 0.9% of its 52-week range. The latest completed week returned -28.9%, after a -30.7% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 1.6x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
30 Jan
6 Feb
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest -0.0012-week average 0.02
12-week confirmation
Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure0/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure-0.00Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is -30.7% over four weeks, -54.1% over 12 weeks, and -74.7% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year16
Trend breadth30.8%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure-0.79Latest activity-pressure read.
Pressure change-6.0%Four-week change in activity pressure.
Leadership-70.30Latest relative-leadership reading.
RS change-14.5%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive.
Factor week 26 Jul 2026
Financial statements through 31 Dec 2025
Field coverage 82%
Model confidence 78%
Relative factor standing
Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.
Overall factor strength71/100Blend of value, momentum, and quality. Underlying universe rank 30; rank 1 is best.
Value60/100Relative valuation strength. Underlying universe rank 41; rank 1 is best.
Quality58/100Profitability and accounting quality. Underlying universe rank 43; rank 1 is best.
Momentum60/100Medium-term price momentum. Underlying universe rank 41; rank 1 is best.
Growth60/100Revenue and earnings growth. Underlying universe rank 41; rank 1 is best.
Quality and valuation are separate questions
A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.
Valuation
How much investors are paying for earnings, sales, and cash flow.
- P/E
- - Price divided by trailing earnings.
- Price / sales
- 1.2x Market value relative to trailing revenue.
- EV / EBITDA
- - Enterprise value relative to operating cash earnings.
- Free-cash-flow yield
- -12.7% Free cash flow as a share of enterprise value.
Business quality
Margins and the return generated on invested capital.
- Gross margin
- 59.5% Gross profit retained from each unit of revenue.
- Operating margin
- -23.7% Operating profit retained from revenue.
- Free-cash-flow margin
- -14.7% Free cash flow generated from revenue.
- Return on invested capital
- -30.8% Operating return generated on invested capital.
Growth and financial strength
Recent business growth and accounting strength.
- Revenue growth
- 26.9% Latest one-year revenue growth.
- EPS growth
- - Latest one-year earnings-per-share growth.
- Free-cash-flow growth
- - Latest one-year free-cash-flow growth.
- Piotroski F-score
- 4/9 Nine-point accounting-strength checklist.
Shareholder return and balance sheet
Cash returned to owners and financial leverage.
- Dividend yield
- - Cash dividends relative to market value.
- Buyback yield
- -42.0% Net share repurchases relative to market value.
- Shareholder yield
- -42.0% Dividend yield plus net buyback yield.
- Net debt / EBITDA
- 0.4x Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment52/100
Weighted news tone is neutral across 44 relevant articles.
7 positive · 36 neutral · 1 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings11dNext report is scheduled for 10 Aug 2026; event risk rises as the date approaches.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-85.0%Distance below the 52-week high.
13-week volatility9.1%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
30 Jan
27 Feb
27 Mar
24 Apr
22 May
19 Jun
24 Jul
Weeks higher9 of 2615 weeks finished lower.
Best week+3.6%Week of 3 Jul.
Worst week-28.9%Week of 24 Jul.
Latest week-28.9%Week of 24 Jul.
Shape of recent returns
Strong gains0
Modest gains9
Flat weeks2
Modest losses7
Sharp losses8
Recent vol9.1%13-week weekly-return volatility.
Base vol10.4%52-week weekly-return volatility.
Up/down split22/28Count of positive and negative weeks in the 52-week window.
Average skew6.3% / -8.7%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorUS Consumer Defensive
4-week rank- / 100
Group average-0.3%
Trend breadth49.0%
Trend49.0%active weekly trend signals
MD58.0%positive activity pressure
RS33.0%positive relative leadership
Four-week leaders
IndustryUS Packaged Foods
4-week rank54 / 58
Group average-4.1%
Trend breadth34.5%
Trend34.5%active weekly trend signals
MD53.4%positive activity pressure
RS22.4%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape26/100
Trend, activity pressure, participation, and risk combine to a 26/100 tape read.
Indicator analysis18/100Latest 12-week confirmation: trend 0/12, activity pressure 0/12, relative leadership 0/12.
Activity pressure -0.00; No reversal markers Factors62/100O'Shaughnessy factor stack blends value, quality, momentum, and confidence.
Buyback Yield rank 95 Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment52/100Weighted news tone is neutral across 44 relevant articles.
BioHarvest Sciences Inc. (NASDAQ: BHST) sets Aug. 11 Q2 2026 earnings call Insiders50/100No recent insider transaction evidence is stored.
Earnings11dNext report is scheduled for 10 Aug 2026; event risk rises as the date approaches.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 24 Jul 2026 | 1.92 USD | -28.9% | 4.05 USD | 4.28 USD | -0.79 | -70.30 | 280.2K | Off |
| 17 Jul 2026 | 2.70 USD | -2.9% | 4.17 USD | 4.27 USD | -0.79 | -59.77 | 266.1K | Off |
| 10 Jul 2026 | 2.78 USD | -3.1% | 4.25 USD | 4.25 USD | -0.83 | -60.96 | 190.4K | Off |
| 3 Jul 2026 | 2.87 USD | 3.6% | 4.33 USD | 4.23 USD | -0.83 | -59.69 | 145.0K | Off |
| 26 Jun 2026 | 2.77 USD | -15.0% | 4.45 USD | 4.22 USD | -0.75 | -61.39 | 132.8K | Off |
| 19 Jun 2026 | 3.26 USD | 1.9% | 4.58 USD | 4.20 USD | -0.61 | -57.28 | 47.2K | Off |
| 12 Jun 2026 | 3.20 USD | 0.3% | 4.67 USD | 4.18 USD | -0.55 | -57.66 | 83.2K | Off |
| 5 Jun 2026 | 3.19 USD | -17.4% | 4.80 USD | 4.16 USD | -0.39 | -57.54 | 189.5K | Off |
| 29 May 2026 | 3.86 USD | 0.0% | 4.94 USD | 4.14 USD | -0.29 | -51.69 | 105.7K | Off |
| 22 May 2026 | 3.86 USD | -5.9% | 5.11 USD | 4.12 USD | -0.27 | -50.90 | 102.3K | Off |
| 15 May 2026 | 4.10 USD | 3.3% | 5.36 USD | 4.09 USD | -0.12 | -47.85 | 151.9K | Off |
| 8 May 2026 | 3.97 USD | -5.0% | 5.59 USD | 4.07 USD | -0.11 | -50.25 | 343.6K | Off |
| 1 May 2026 | 4.18 USD | -4.6% | 5.83 USD | 4.04 USD | -0.01 | -45.45 | 189.5K | Off |
| 24 Apr 2026 | 4.38 USD | 0.7% | 5.98 USD | 4.02 USD | 0.08 | -42.66 | 76.6K | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.